½ÃÀ庸°í¼­
»óǰÄÚµå
1447631

¸»ÃÊ Á¤¸Æ Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ·ç¸àº°, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2024-2032³â)

Peripheral Intravenous Catheters Market-By Product (Short PIVC, Integrated/Closed PIVC), Technology (Conventional PIVC, Safety PIVC), Lumen (Single, Double, Multi-lumen), End-use (Hospitals, Ambulatory Surgical Centers)-Global Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸»ÃÊ Á¤¸Æ Ä«Å×ÅÍ(PIVC) ½ÃÀå ±Ô¸ð´Â ÀÇ·á ºÐ¾ß¿¡¼­ Ä«Å×ÅÍ ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ Áö¿ø ±â±âÀÇ µµÀÔÀ¸·Î ÀÎÇØ 2024-2032³â 7.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ À¯ÀÔÀ¸·Î ¸»ÃÊ Á¤¸Æ Ä«Å×ÅÍ(PIVC)´Â ´Ù¾çÇÑ ÀÇ·á ½Ã¼ú¿¡¼­ ±â´É¼º°ú È¿´ÉÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 10¿ù Linear Health SciencesÀÇ ÀÇ·á±â±âÀÎ Orchid SRV ¾ÈÀü ÇØÁ¦ ¹ëºê´Â FDAÀÇ ÀûÀÀÁõ È®´ë¸¦ ¹Þ¾Ò½À´Ï´Ù. À̹ø ÀûÀÀÁõ È®´ë·Î Orchid SRV´Â ¸ðµç Á¤¸Æ Á¢±Ù ¹æ¹ý¿¡ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

Ä«Å×ÅÍ »ðÀÔ, °íÁ¤ ¹× À¯Áöº¸¼ö¸¦ ÃÖÀûÈ­Çϴ ÷´Ü Àåºñ °³¹ß·Î ÀÇ·áÁøÀº ¾ÈÁ¤ÀûÀÎ Á¤¸Æ Á¢±ÙÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ ȯÀÚÀÇ Æí¾ÈÇÔ°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ º¸Á¶ ±â¼ú º¸±ÞÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ »ê¾÷ È®ÀåÀÇ ÇÑ ÃàÀ» ´ã´çÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

±â¼úº°·Î´Â ±âÁ¸ PIVC ºÐ¾ß°¡ 2024-2032³â ¿¬Æò±Õ 7.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ½ÃÀå Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Ä«Å×ÅÍ´Â ´Ü±â°£ÀÇ Á¤¸Æ³» Ä¡·á¸¦ À§ÇØ ÀÇ·á ȯ°æ¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ȯÀÚ Ä¡·á¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. µðÀÚÀΰú ¼ÒÀçÀÇ ¹ßÀüÀ¸·Î ±âÁ¸ PIVC´Â »ðÀÔ ±â¼ú°ú ȯÀÚ ÆíÀǼºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ¹ü¿ë¼º°ú ½Å·Ú¼ºÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ ÀÇ·á ½Ã¼ú¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ÀÇ·á ±â°üÀº ȯÀÚÀÇ ¾ÈÀü°ú È¿À²¼ºÀ» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ±âÁ¸ PIVC¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Îµµ °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿Ü·¡È¯ÀÚ ¼ö¼ú¼¾ÅÍ ÃÖÁ¾ ¿ëµµ ºÎ¹®ÀÇ ¸»ÃÊ Á¤¸Æ Ä«Å×ÅÍ ½ÃÀå ¸ÅÃâÀº 2024-2032³â 8.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)´Â ¿Ü·¡ ȯÀÚ ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ Á¤¸Æ Á¢±Ù¿¡ ´ëÇÑ Çʿ伺ÀÌ °¡Àå ³ôÀº °÷À¸·Î, PIVC´Â ÀÌ·¯ÇÑ ¼¾ÅÍÀÇ ¼ö¼ú ¹× Áø´Ü ÀýÂ÷¿¡¼­ ¾ÈÀüÇÏ°í Æí¸®ÇÑ ¾à¹° ¹× ¼ö¾× Àü´ÞÀ» ¿ëÀÌÇÏ°Ô Çϸç, ASC´Â ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀÌ°í ³·Àº ħ½À¼º ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¦Ç° ¼ö¿ä¸¦ ¿ì¼±½ÃÇÕ´Ï´Ù. Àúħ½ÀÀûÀÎ ¼Ö·ç¼ÇÀ» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦Ç° ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ ¸»ÃÊ Á¤¸Æ Ä«Å×ÅÍ »ê¾÷Àº 2024-2032³â ¿¬Æò±Õ 7.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ±â¼ú ¹ßÀü¿¡ ÁßÁ¡À» µÐ À¯·´ÀÇ º´¿ø ¹× Ŭ¸®´ÐÀº Á¤¸Æ³» Ä¡·á ÀýÂ÷¸¦ °£¼ÒÈ­Çϱâ À§ÇØ ½Å·ÚÇÒ ¼ö ÀÖ°í ´ÙÀç´Ù´ÉÇÑ PIVC¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ°¡ µµ·¡Çϰí ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇÔ¿¡ µû¶ó ȯÀÚÀÇ ÆíÀǼºÀ» °³¼±Çϰí ÇÕº´Áõ À§ÇèÀ» ÁÙÀÌ´Â Çõ½ÅÀûÀÎ Ä«Å×ÅÍ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯÀÇ Áõ°¡
      • Á¤¸Æ³» Ä¡·á¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡
      • Ä«Å×ÅÍÀÇ ±â¼úÀû Áøº¸
      • Àúħ½À¼ö¼ú·ÎÀÇ À̵¿
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • Ä«Å×ÅÍ °ü·Ã °¨¿°ÀÇ ¸®½ºÅ©¿Í ÇÕº´Áõ
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®
  • »óȯ ½Ã³ª¸®¿À
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¼îÆ® PIVC
  • ÅëÇÕ/Ŭ·ÎÁîµå PIVC

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ±â¼úº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ±âÁ¸Çü PIVC
  • ¾ÈÀüÇÑ PIVC

Á¦7Àå ½ÃÀå ¿¹Ãø : ·ç¸àº° ½ÃÀå Ã߻ꡤ¿¹Ãø : ·ç¸àº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ½Ì±Û ·ç¸à
  • ´õºí ·ç¸à
  • ¸ÖƼ ·ç¸à

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ °³¿ä

  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ICU Medical, Inc.
  • Lineus Medical
  • MedSource Labs
  • Retractable Technologies Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • VOGT Medical
  • Vygon
KSA 24.03.26

Global Peripheral Intravenous Catheters Market size is expected to record 7.7% CAGR between 2024 and 2032 due to the introduction of supportive devices utilizing catheter systems in the medical sector. The influx of innovations is complementing peripheral intravenous catheters (PIVC) with enhanced functionality and efficacy in various medical procedures. For instance, in October 2023, a medical device, Orchid SRV safety release valve from Linear Health Sciences received expanded FDA indication. This expansion allowed Orchid SRV to be utilized with all IV access methods.

With the development of advanced devices that optimize catheter insertion, securement, and maintenance, healthcare providers are improving patient comfort and safety while ensuring reliable intravenous access. The rising penetration of supportive technologies in the medical sector will also outline the industry expansion.

The overall peripheral intravenous catheters industry is segmented into product, technology, lumen, end-use, and region.

Based on technology, the market share from the conventional PIVC segment will record 7.4% CAGR from 2024 to 2032. These catheters are widely used in healthcare settings for short-term intravenous therapy, emerging pivotal for patient care. With advancements in design and materials, conventional PIVCs offer improved insertion techniques and patient comfort. Their versatility and reliability make them essential for various medical procedures. With healthcare facilities prioritizing patient safety and efficiency, the demand for conventional PIVC segment will continue to rise.

Peripheral intravenous catheters market revenue from the ambulatory surgical centers end-use segment will register 8.6% CAGR from 2024 to 2032. With ambulatory surgical centers (ASCs) increasingly performing outpatient procedures, the need for reliable and efficient intravenous access has become paramount. PIVCs facilitate the safe and convenient delivery of medications and fluids during surgical and diagnostic procedures in these centers. ASCs are also prioritizing cost-effective and minimally invasive solutions, further driving the product demand.

Europe peripheral intravenous catheters industry will record 7.1% CAGR from 2024 to 2032. With a strong focus on advancing medical technology, European hospitals and clinics are seeking reliable and versatile PIVCs to streamline intravenous therapy procedures. With the presence of an aging population and evolving healthcare infrastructure, there is an increasing need for innovative catheter solutions that offer improved patient comfort and reduced risk of complications.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Rise in demand for intravenous therapies
      • 3.2.1.3 Technological advancements in catheters
      • 3.2.1.4 Transitioning to minimally invasive surgical procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risks and complications of catheter-associated infections
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Short PIVC
  • 5.3 Integrated/closed PIVC

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Conventional PIVC
  • 6.3 Safety PIVC

Chapter 7 Market Estimates and Forecast, By Lumen, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Single lumen
  • 7.3 Double lumen
  • 7.4 Multi-lumen

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AngioDynamics, Inc.
  • 10.2 Becton, Dickinson and Company
  • 10.3 B. Braun Melsungen AG
  • 10.4 Boston Scientific Corporation
  • 10.5 ICU Medical, Inc.
  • 10.6 Lineus Medical
  • 10.7 MedSource Labs
  • 10.8 Retractable Technologies Inc.
  • 10.9 Teleflex Incorporated
  • 10.10 Terumo Corporation
  • 10.11 VOGT Medical
  • 10.12 Vygon
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦